Clinical Trials Logo

Clinical Trial Summary

The main objective of this study is to carry out a descriptive study of the clinical and demographic characteristics of patients having consulted for a specialized opinion about ADHD in adults of the psychiatric service of the Strasbourg University Hospital.

The characteristics of patients were collected during the first consultation, by the psychiatrist, and analyzed retrospectively.

The secondary objective is to evaluate the evolution at one year in terms of follow-up, maintenance under medical treatment and perceived effects of it.

The patients who had a prescription for pharmacological treatment of ADHD were contacted between 9 and 15 months after the first consultation and responded to a questionnaire assessing the evolution.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms

  • Attention Deficit and Hyperactivity Disorder
  • Attention Deficit Disorder with Hyperactivity
  • Hyperkinesis

NCT number NCT03601858
Study type Observational
Source University Hospital, Strasbourg, France
Contact Sébastien Weibel, MD
Phone 33 3 88 11 51 57
Email sebastien.weibel@chru-strasbourg.fr
Status Recruiting
Phase
Start date June 1, 2018
Completion date June 2019

See also
  Status Clinical Trial Phase
Completed NCT01174355 - A Study of ND0801 in Attention Deficit/Hyperactivity Disorder (ADHD) Phase 1/Phase 2
Completed NCT05935254 - Plaque Removal Efficacy of Electric Toothbrushes in ADHD N/A